Voleon Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$67.8M Buy
73,676
+33,146
+82% +$33.6M 1.46% 8
2025
Q4
$43.6M Buy
40,530
+24,565
+154% +$23.5M 0.94% 12
2025
Q3
$12.2M Sell
15,965
-3,051
-16% -$2.27M 0.3% 66
2025
Q2
$14.8M Buy
19,016
+9,263
+95% +$7.2M 0.81% 18
2025
Q1
$8.06M Buy
9,753
+2,415
+33% +$2.01M 0.63% 39
2024
Q4
$5.66M Buy
+7,338
New +$6.08M 0.42% 60
2019
Q3
Sell
-62,000
Closed -$6.87M 205
2019
Q2
$6.87M Buy
+62,000
New +$7.3M 0.39% 59

Other funds holding LLY

Voleon Capital Management's LLY Position: Q1 2026 in Review

Voleon Capital Management increased its Eli Lilly (LLY) stake by 82% in Q1 2026, buying an estimated $33.6M and bringing the position to 73,676 shares worth $67.8M. The position accounts for 1.46% of the portfolio, ranked #8.

Voleon Capital Management first reported a position in LLY in Q2 2019 and has held it in 7 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Voleon Capital Management held 73,676 shares of Eli Lilly worth $67.8M as of Q1 2026.
  • Voleon Capital Management bought 33,146 Eli Lilly shares in Q1 2026, an estimated $33.6M.
  • Eli Lilly made up 1.46% of Voleon Capital Management's portfolio in Q1 2026, its #8 holding.
  • Voleon Capital Management first reported a position in Eli Lilly in Q2 2019 and has held it in 7 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.